Shibuya Y, Yamamoto T, Tanaka H, Semba U, Kambara T, Okabe H
Department of Laboratory Medicine, Kumamoto University Medical School, Japan.
Clin Chim Acta. 1991 Aug 30;200(2-3):119-27. doi: 10.1016/0009-8981(91)90083-o.
An automated assay of plasma prekallikrein is described. Prekallikrein was converted to kallikrein with Pseudomonas aeruginosa elastase, and the hydrolytic activity of kallikrein to H-D-Pro-Phe-Arg-paranitroanilide subsequently measured. The conversion was complete within 8 minutes and the amidolytic activity remained stable at least another 10 min at 37 degrees C. This method worked in plasma deficient in Hageman factor (blood coagulation factor XII). Using anti-prekallikrein antibody and plasma deficient in prekallikrein, the amidolytic activity generated in normal plasma was identified as due to kallikrein. With plasma samples, the coefficients of variation (CV) for multiple measurements within run (n = 10) and between run (n = 10) were as low as 5.0% and 6.6%, respectively, and the minimum measurable concentration of prekallikrein in plasma was 10% of the normal level.
本文描述了一种血浆前激肽释放酶的自动化检测方法。用铜绿假单胞菌弹性蛋白酶将前激肽释放酶转化为激肽释放酶,随后测定激肽释放酶对H-D-脯氨酸-苯丙氨酸-精氨酸-对硝基苯胺的水解活性。在8分钟内转化完成,在37℃下,酰胺水解活性至少在另外10分钟内保持稳定。该方法适用于缺乏Hageman因子(凝血因子XII)的血浆。使用抗前激肽释放酶抗体和缺乏前激肽释放酶的血浆,正常血浆中产生的酰胺水解活性被鉴定为是由激肽释放酶引起的。对于血浆样本,批内多次测量(n = 10)和批间多次测量(n = 10)的变异系数(CV)分别低至5.0%和6.6%,血浆中前激肽释放酶的最低可测浓度为正常水平的10%。